Yunshan Peng

Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells

Jie Cai, Vijaya L. Damaraju, Normand Groulx et al. · Cancer Research · 2008 · 92 citations · Full text

Medicine, Cancer Biology, Pharmacology +16

Design, Synthesis, and Properties of a Potent Inhibitor of<i>Pseudomonas aeruginosa</i>Deacetylase LpxC

Grazia Piizzi, David T. Parker, Yunshan Peng et al. · Journal of Medicinal Chemistry · 2017 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Residues 334 and 338 in Transmembrane Segment 8 of Human Equilibrative Nucleoside Transporter 1 Are Important Determinants of Inhibitor Sensitivity, Protein Folding, and Catalytic Turnover

Frank Visser, Lijie Sun, Vijaya L. Damaraju et al. · Journal of Biological Chemistry · 2007 · 46 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

Improved Syntheses of 5′-<i>S</i>-(2-Aminoethyl)-6-<i>N</i>-(4-nitrobenzyl)-5′-thioadenosine (SAENTA), Analogues, and Fluorescent Probe Conjugates: Analysis of Cell-Surface Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels for Prediction of the Antitumor Efficacy of Gemcitabine

Morris J. Robins, Yunshan Peng, Vijaya L. Damaraju et al. · Journal of Medicinal Chemistry · 2010 · 35 citations

Medicine, Oncology, Pharmacology +12

Potent Nonimmunosuppressive Cyclophilin Inhibitors With Improved Pharmaceutical Properties and Decreased Transporter Inhibition

Jiping Fu, Meiliana Tjandra, Christopher Becker et al. · Journal of Medicinal Chemistry · 2014 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17